Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 28, 2017

DrugPatentWatch Database Preview

PROZAC Drug Profile

« Back to Dashboard

What is the patent landscape for Prozac, and what generic alternatives are available?

Prozac is a drug marketed by Lilly and Eli Lilly And Co and is included in four NDAs. There are four patents protecting this drug.

This drug has twenty-five patent family members in twenty-three countries.

The generic ingredient in PROZAC is fluoxetine hydrochloride. There are twenty-seven drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the fluoxetine hydrochloride profile page.

Summary for Tradename: PROZAC

Suppliers / Packagers: see list2
Bulk Api Vendors: see list83
Clinical Trials: see list18
Patent Applications: see list3,088
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PROZAC at DailyMed

Pharmacology for Tradename: PROZAC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
fluoxetine hydrochloride
SOLUTION;ORAL020101-001Apr 24, 1991DISCNYesNo► Subscribe► Subscribe
Eli Lilly And Co
fluoxetine hydrochloride
CAPSULE;ORAL018936-003Jun 15, 1999ABRXYesYes► Subscribe► Subscribe
Eli Lilly And Co
fluoxetine hydrochloride
CAPSULE;ORAL018936-001Dec 29, 1987AB1RXYesNo6,960,577► Subscribe ► Subscribe
Eli Lilly And Co
fluoxetine hydrochloride
CAPSULE;ORAL018936-004Jun 15, 1999DISCNNoNo► Subscribe► Subscribe
fluoxetine hydrochloride
CAPSULE, DELAYED REL PELLETS;ORAL021235-001Feb 26, 2001ABRXYesYes5,985,322*PED► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Uncover prior art in abandoned patent applications and expired patents
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus